Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mitsuho Imai"'
Autor:
Tadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, Satoshi Yuki, Naoki Takahashi, Naohiro Okano, Hidekazu Hirano, Koushiro Ohtsubo, Takashi Ohta, Eiji Oki, Tomohiro Nishina, Hisateru Yasui, Hisato Kawakami, Taito Esaki, Nozomu Machida, Ayako Doi, Shogen Boku, Toshihiro Kudo, Yoshiyuki Yamamoto, Akiyoshi Kanazawa, Tadamichi Denda, Masahiro Goto, Naoko Iida, Hiroshi Ozaki, Taro Shibuki, Mitsuho Imai, Takao Fujisawa, Hideaki Bando, Yoichi Naito, Takayuki Yoshino
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-10 (2024)
Abstract Background While advanced gastrointestinal stromal tumors (GISTs) are primarily treated with tyrosine kinase inhibitors (TKIs), acquired resistance from specific mutations in KIT or PDGFRA frequently occurs. We aimed to assess the utility of
Externí odkaz:
https://doaj.org/article/8d89e02235024fa88d2552871e8438cb
Autor:
Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Hidetaka Nomura, Mitsuho Imai, Hideyuki Hayashi, Hiroshi Nishihara
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-5 (2020)
Abstract Background Bartholin gland carcinomas (BGCs) are rare tumor types, for which no molecular analyses including genomic sequencing have been reported to date. Adenoid cystic carcinomas (ACCs) of the Bartholin’s glands are an atypical histolog
Externí odkaz:
https://doaj.org/article/679fbc7a5ba34ffca2302da2608b70df
Autor:
Mitsuho Imai-Sumida, Pritha Dasgupt, Priyanka Kulkarni, Marisa Shiina, Yutaka Hashimoto, Varahram Shahryari, Shahana Majid, Yuichiro Tanaka, Rajvir Dahiya, Soichiro Yamamura
Publikováno v:
Cellular Physiology and Biochemistry, Vol 54, Iss 1, Pp 53-70 (2020)
Externí odkaz:
https://doaj.org/article/50f77288c4354436acacd01da62a29c9
Autor:
Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Mitsuho Imai, Akiko Kawano Nagatsuma, Hideyuki Hayashi, Yuki Yoshimura, Kentaro Nakayama, Satoru Kyo, Hiroshi Nishihara
Publikováno v:
Diagnostics, Vol 10, Iss 4, p 200 (2020)
Precision medicine, which includes comprehensive genome sequencing, is a potential therapeutic option for treating high-grade serous carcinoma (HGSC). However, HGSC is a heterogeneous tumor at the architectural, cellular, and molecular levels. Intrat
Externí odkaz:
https://doaj.org/article/dad0432733984610a93bbe9bb0b39f8e
Autor:
Mitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, Hidenori Kage, Keigo Komine, Takafumi Koyama, Toraji Amano, Daisuke Ennishi, Masashi Kanai, Hirotsugu Kenmotsu, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Hideaki Bando, Akitaka Makiyama, Tatsuya Suzuki, Makoto Hirata, Shinji Kohsaka, Katsuya Tsuchihara, Yoichi Naito, Takayuki Yoshino
Publikováno v:
Cancer Science. 113:3646-3656
Comprehensive genomic profiling is increasingly used to facilitate precision oncology based on molecular stratification. In addition to conventional tissue comprehensive genomic profiling, comprehensive genomic profiling of circulating tumor DNA has
Autor:
Kuniko Sunami, Yoichi Naito, Keigo Komine, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Shinji Kohsaka, Katsuya Tsuchihara, Yusuke Saigusa, Takayuki Yoshino
Publikováno v:
Cancer Science. 113:3995-4000
In Japan, comprehensive genomic profiling (CGP) tests for refractory cancer patients have been approved since June 2019, under the requirement that all cases undergoing CGP tests are annotated by the molecular tumor board (MTB) at each government-des
Autor:
Satoru Kyo, Shigeki Tanishima, Yuki Yoshimura, Hideyuki Hayashi, Eriko Aimono, Kentaro Nakayama, Kohei Nakamura, Mitsuho Imai, Akiko Kawano Nagatsuma, Hiroshi Nishihara
Publikováno v:
JCO Precision Oncology
Autor:
Hideyuki Hayashi, Shigeki Tanishima, Kaori Mochida, Tomoka Fujikura, Sachiko Hagiwara, Emmy Yanagita, Hiroshi Yamada, Ryutaro Kawano, Kohei Nakamura, Marin Ishikawa, Yasutaka Kato, Eriko Aimono, Mitsuho Imai, Arisa Ueki, Hiroshi Nishihara
Publikováno v:
Annals of Oncology. 33:S479-S480
Autor:
Yoichi, Naito, Kuniko, Sunami, Hidenori, Kage, Keigo, Komine, Toraji, Amano, Mitsuho, Imai, Takafumi, Koyama, Daisuke, Ennishi, Masashi, Kanai, Hirotsugu, Kenmotsu, Takahiro, Maeda, Sachi, Morita, Daisuke, Sakai, Kousuke, Watanabe, Hidekazu, Shirota, Ichiro, Kinoshita, Masashiro, Yoshioka, Nobuaki, Mamesaya, Mamoru, Ito, Shinji, Kohsaka, Yusuke, Saigusa, Kouji, Yamamoto, Makoto, Hirata, Katsuya, Tsuchihara, Takayuki, Yoshino
Publikováno v:
JAMA Network Open. 5:e2245081
ImportanceQuality assurance of molecular tumor boards (MTBs) is crucial in cancer genome medicine.ObjectiveTo evaluate the concordance of recommendations by MTBs and centrally developed consensus treatment recommendations at all 12 leading institutio
Autor:
Kuniko Sunami, Yoichi Naito, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Keigo Komine, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Yusuke Saigusa, Daisuke Sakai, Ichiro Kinoshita, Toshiyuki Kozuki, Hiroyuki Sakashita, Shinji Kohsaka, Katsuya Tsuchihara, Takayuki Yoshino
Publikováno v:
Journal of Clinical Oncology. 40:11032-11032
11032 Background: Treatment recommendations (TRs) by molecular tumor boards (MTBs) based on comprehensive genomic profiling tests are crucial for enrolling cancer patients in genotype-matched trials. Our previous study of Japanese designated ‘Core